News | Radiation Oncology | May 23, 2023

Centre de Cancérologie de la Porte de Saint-Cloud in Boulogne unveils the latest advance in completely non-invasive brain tumor therapy

Centre de Cancérologie de la Porte de Saint-Cloud in Boulogne unveils the latest advance in completely non-invasive brain tumor therapy

May 23, 2023 — ZAP Surgical Systems, Inc., a leading innovator in the field of surgical robotics, today announced that Centre de Cancérologie de la Porte de Saint-Cloud (CCPSC) in Boulogne, France, has initiated patient treatments with the ground-breaking ZAP-X Gyroscopic Radiosurgery platform. CCPSC is the first in France to offer ZAP-X and is part of the renowned American Hospital of Paris, known for offering the most innovative technologies and most advanced treatment methods. CCPSC treated three patients on their first day, each with a single brain metastasis.

As a non-invasive and painless treatment for select primary and metastatic brain tumors, stereotactic radiosurgery (SRS) has proven to provide equivalent to superior outcomes compared to costly and potentially debilitating surgeries. SRS is typically delivered in one to five brief outpatient visits and patients often return to normal activity the same day as the procedure.

“Because of the significant percentage of cancer patients who develop brain metastases, it was imperative we support our radiation oncology program with a dedicated SRS solution such as ZAP-X,” said Dr. Bacem Belghith, radiation oncologist at the CCPSC.

“As ZAP-X is designed specifically for cranial radiosurgery it allows us to treat the most challenging cases with confidence,” added Dr. Alain Allaw, radiation oncologist at the CCPSC. “And unlike multi-purpose radiotherapy devices, ZAP-X provides patients with potentially lower healthy brain exposure to radiation, and thus enables greater flexibility for our clinical team to treat recurring brain metastases patients.”

The ZAP-X system uses unique gyroscopic mobility to direct radiosurgical beams from hundreds of angles to precisely concentrate radiation on the tumor target. This pioneering approach supports the clinical objective of protecting healthy brain tissue and patient cognitive function.

As the first and only vault-free and cobalt-free dedicated SRS delivery system, ZAP-X also eliminates the expense of building costly shielded radiation treatment rooms, and removes the need to maintain, secure and regularly replace live radioactive isotopes.

“As the first center to retrofit an existing shielded radiotherapy suite, ZAP-X has seamlessly integrated into CCPSC’s busy radiation oncology department, and now serves as the centerpiece of an elite SRS program,” said Hakan Baraner, ZAP Surgical’s Senior Vice President for Europe, India, Middle East, and Africa (EIMEA). “ZAP is incredibly honored to support CCPSC in bringing world-class care to their patients.”

To view video footage of CCPSC’s ZAP-X treatment suite please visit: https://youtu.be/De3b_MpT__4.

For more information: www.zapsurgical.com

Related Brain Metastases Content: 

Novel Radiomic Model Helps Predict the Treatment Response of Radiotherapy in Patients with Brain Metastases

PET Imaging Adds Valuable Information to Brain Metastasis Monitoring 

Blue Earth Diagnostics Announces Dosing of Initial Patient in Phase 3 REVELATE Clinical Trial of 18F-Fluciclovine PET Imaging for Detection of Recurrent Brain Metastases 

Radiosurgery Reduces Cognitive Decline Without Compromising Survival for Patients with 4+ Brain Metastases 

ASTRO Issues Clinical Guideline on Radiation Therapy for Brain Metastases 


Related Content

News | Prostate Cancer

September 22, 2023 — According to an accepted manuscript published in the American Journal of Roentgenology (AJR) ...

Time September 22, 2023
arrow
Feature | Radiation Oncology

The radiation oncology community lost a leader this past summer, with the passing of Jay Loeffler, MD, FACR, FASTRO. He ...

Time September 21, 2023
arrow
Feature | Proton Therapy | By Christine Book

An overview of significant developments in proton therapy, over just the past six months, reinforces the pace of ...

Time September 21, 2023
arrow
News | Radiation Therapy

September 20, 2023 — RefleXion Medical, Inc., a therapeutic oncology company and 3B Pharmaceuticals (3BP) GmbH, a ...

Time September 20, 2023
arrow
News | Ultrasound Imaging

September 8, 2023 — When diagnosing and treating cancer patients, the dynamics of blood flow to and from a suspected ...

Time September 08, 2023
arrow
News | ASTRO

September 7, 2023 — American Society for Radiation Oncology (ASTRO) President Jeff Michalski, MD, MBA, FASTRO, will join ...

Time September 07, 2023
arrow
News | Radiation Oncology

September 6, 2023 — Nina D’Abreo, MD, has been named as chief of the Division of Hematology and Medical Oncology at NYU ...

Time September 06, 2023
arrow
Feature | Radiology Business | By Melinda Taschetta-Millane

As we wind down the summer months, ITN takes a look at the Top 10 most-read pieces of content from www.itnonline.com ...

Time August 31, 2023
arrow
News | Radiation Oncology

August 30, 2023 — Elekta and the IAEA have signed a partnership agreement to jointly pursue common interests, including ...

Time August 30, 2023
arrow
News | Radiation Therapy

August 30, 2023 — A published study by researchers at the University of Cincinnati Cancer Center and Cincinnati Children ...

Time August 30, 2023
arrow
Subscribe Now